Cetera Investment Advisers’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
AAP
FIB
RA
SPIA
Cetera Investment Advisers's REVS Position: Q2 2026 in Review
Cetera Investment Advisers increased its Columbia Research Enhanced Value ETF (REVS) stake by 1,983% in Q2 2026, buying an estimated $6.4M and bringing the position to 218,111 shares worth $6.86M. The position accounts for 0.01% of the portfolio, ranked #1384.
Cetera Investment Advisers first reported a position in REVS in Q1 2024 and has held it in 3 quarters since. 38 funds tracked by Wall St. Rank hold REVS as of Q2 2026.
- Cetera Investment Advisers held 218,111 shares of Columbia Research Enhanced Value ETF worth $6.86M as of Q2 2026.
- Cetera Investment Advisers bought 207,641 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $6.4M.
- Columbia Research Enhanced Value ETF made up 0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1384 holding.
- Cetera Investment Advisers first reported a position in Columbia Research Enhanced Value ETF in Q1 2024 and has held it in 3 quarters since.
- 38 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.
Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.